Ruxolitinib as a promising treatment for corticosteroid-refractory graft-versus-host disease

被引：22
作者：
Assouan, Deborah [1 ]
Lebon, Delphine [1 ]
Charbonnier, Amandine [1 ]
Royer, Bruno [1 ]
Marolleau, Jean-Pierre [1 ]
Gruson, Berengere [1 ]
机构：
[1] Ctr Hosp Univ Amiens, Hematol, Amiens, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 05期
关键词：
graft-versus-host disease; hematopoietic stem cell transplantation; ruxolitinib; malignant haematology; corticosteroids; TRANSPLANTATION;
D O I：
10.1111/bjh.14679
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：687 / 689
页数：3
相关论文
共 50 条
[41]   Beclometasone dipropionate:: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease [J].
Diez-Campelo, Maria ;
Sanchez-Guijo, Fermin M. ;
Perez Simon, Jose A. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (09) :1389-1401
[42]   Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care [J].
Cazeau, Naomi ;
Rodriguez, Stephany .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (03) :259-265
[43]   Ruxolitinib salvage therapy is effective for steroid-refractory graft-versus-host disease in children: A single-center experience [J].
Uygun, Vedat ;
Karasu, Gulsun ;
Daloglu, Hayriye ;
Ozturkmen, Seda ;
Kilic, Suar Caki ;
Yalcin, Koray ;
Celen, Safiye Suna ;
Hazar, Volkan ;
Yesilipek, Akif .
PEDIATRIC BLOOD & CANCER, 2020, 67 (04)
[44]   Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease [J].
Ringden, Olle ;
Erkers, Tom ;
Nava, Silvia ;
Uzunel, Mehmet ;
Iwarsson, Erik ;
Conrad, Reka ;
Westgren, Magnus ;
Mattsson, Jonas ;
Kaipe, Helen .
STEM CELLS, 2013, 31 (03) :592-601
[45]   Real-world experience with ruxolitinib for steroid-refractory acute graft-versus-host disease: a single center experience [J].
Adrianna Spałek ;
Agata Wieczorkiewicz-Kabut ;
Anna Koclęga ;
Krzysztof Woźniczka ;
Patryk Węglarz ;
Kinga Boral ;
Dariusz Kata ;
Patrycja Zielińska ;
Grzegorz Helbig .
International Journal of Hematology, 2022, 116 :922-928
[46]   FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy [J].
Le, Robert Q. ;
Wang, Xin ;
Zhang, Hongfei ;
Li, Hongshan ;
Przepiorka, Donna ;
Vallejo, Jonathon ;
Leong, Ruby ;
Ma, Lian ;
Goldberg, Kirsten B. ;
Pazdur, Richard ;
Theoret, Marc R. ;
De Claro, Angelo .
ONCOLOGIST, 2022, 27 (06) :493-500
[47]   Ruxolitinib Pharmacokinetics and Pharmacodynamics in Children with Acute and Chronic Graft-versus-Host Disease [J].
Cook, Eleanor ;
Dong, Min ;
Chiang, Samuel C. C. ;
Luedeke, David ;
Lake, Kelly E. ;
Hoerth, Colin ;
Deavy, Marisa ;
Setchell, Kenneth D. R. ;
Zhao, Junfang ;
Galletta, Thomas ;
Punt, Nieko ;
Teusink-Cross, Ashley ;
Davies, Stella M. ;
Marsh, Rebecca A. ;
Mehta, Parinda ;
Khandelwal, Pooja .
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (05) :528.e1-528.e12
[48]   Tocilizumab for steroid refractory acute graft-versus-host disease [J].
Roddy, Julianna V. F. ;
Haverkos, Bradley M. ;
McBride, Ali ;
Leininger, Kathryn M. ;
Jaglowski, Samantha ;
Penza, Sam ;
Klisovic, Rebecca ;
Blum, William ;
Vasu, Sumithira ;
Hofmeister, Craig C. ;
Benson, Don M. ;
Andritsos, Leslie A. ;
Devine, Steven M. ;
Efebera, Yvonne A. .
LEUKEMIA & LYMPHOMA, 2016, 57 (01) :81-85
[49]   Colonic graft-versus-host disease [J].
Ross, WA ;
Couriel, D .
CURRENT OPINION IN GASTROENTEROLOGY, 2005, 21 (01) :64-69
[50]   Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease [J].
Wolff, Daniel ;
Cutler, Corey ;
Lee, Stephanie J. ;
Pusic, Iskra ;
Bittencourt, Henrique ;
White, Jennifer ;
Hamadani, Mehdi ;
Arai, Sally ;
Salhotra, Amandeep ;
Perez-Simon, Jose A. ;
Alousi, Amin ;
Choe, Hannah ;
Kwon, Mi ;
Bermudez, Arancha ;
Kim, Inho ;
Socie, Gerard ;
Chhabra, Saurabh ;
Radojcic, Vedran ;
O'Toole, Timothy ;
Tian, Chuan ;
Ordentlich, Peter ;
Defilipp, Zachariah ;
Kitko, Carrie L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11) :1002-1014
12345